Novartis | NOVN - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Alcon AG USD 2.44B 47M 2026-03
Almirall EUR 178.13M 1.54M 2025-12
Amgen USD 6.22B 34M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
Autolus Therapeutics Ltd USD 33.43M 198K 2026-06
Bayer EUR 11.97B 43M 2026-06
Biogen USD 2.38B 435.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Fresenius EUR 2.73B 119M 2026-03
Fresenius Medical Care EUR 2.33B 28.84M 2026-06
Genmab DKK 21M 8M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
GRIFOLS EUR 3.49B 34M 2026-06
Hikma Pharmaceutical USD 1.11B 24M 2025-12
J&J USD 15.14B 561M 2026-06
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.78B 220M 2026-03
Merck USD 6.21B 272M 2026-06
Novartis USD 6.22B 66M 2026-06
Novartis USD 6.29B 135M 2026-03
Novo Nordisk DKK 45.65B 21.26B 2025-06
Orion EUR 512.2M 55.9M 2026-03
Pfizer USD 9.94B 722M 2026-06
Philips EUR 3.22B 106M 2026-06
Recordati EUR 550.34M 4.52M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
UCB EUR 1.31B 173M 2024-12